Health Care & Life Sciences » Biotechnology | U.S. Stem Cell Inc.

U.S. Stem Cell Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
46.20
36.70
58.40
270.70
986.80
1,357.10
Total Accounts Receivable
19.90
95.40
35.00
16.00
43.00
18
Inventories
-
-
17.40
42.20
70.40
93.20
Other Current Assets
0.80
9.30
4.80
-
3.10
38.10
Total Current Assets
66.90
141.30
115.60
329.00
1,103.30
1,506.50
Net Property, Plant & Equipment
9.10
12.70
14.20
21.00
449.70
242.60
Total Investments and Advances
-
40.60
89.10
67.50
34.90
57.80
Other Assets
10.20
10.20
10.20
10.20
10.20
10.20
Total Assets
86.10
204.80
229.10
427.60
1,598.10
1,817.10
ST Debt & Current Portion LT Debt
7,046.10
6,106.10
2,406.70
2,974.20
3,246.10
Accounts Payable
2,382.30
1,992.00
1,503.50
1,290.30
1,378.10
Other Current Liabilities
4,001.00
3,000.70
1,794.40
1,899.00
1,839.20
Total Current Liabilities
13,429.40
11,098.80
5,704.60
6,163.50
6,463.40
Long-Term Debt
-
-
2,246.00
2,211.30
1,916.10
Other Liabilities
403.80
-
-
71.50
318.80
Total Liabilities
13,833.20
11,098.80
7,950.60
8,446.30
8,698.40
Common Equity (Total)
13,767.10
10,914.00
7,741.40
8,038.60
7,100.30
Total Shareholders' Equity
13,747.10
10,894.00
7,721.40
8,018.60
7,100.30
Total Equity
13,747.10
10,894.00
7,721.40
8,018.60
7,100.30
Liabilities & Shareholders' Equity
86.10
204.80
229.10
427.60
1,598.10
Preferred Stock (Carrying Value)
20.00
20.00
20.00
20.00
-

About U.S. Stem Cell

View Profile
Address
13794 NW 4th Street
Sunrise Florida 33325
United States
Employees -
Website http://www.us-stemcell.com
Updated 07/08/2019
U. S. Stem Cell, Inc. engages on the discovery, development, and subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.